On the contrary, some genetic obesity disorders related to the impairment of MC4R signalling (i.e., Bardet–Biedl syndrome) characterised by significant hyperphagia showed an excellent response to setmelanotide, a selective agonist of MC4R [59]. Here, MC4R is linked to Bardet-Biedl syndrome.